Submucosal Dexamethasone After Tonsillectomy

Sex: All

Ages: 18 Years – 44 Years

Healthy volunteers: No

Phase: PHASE4

Enrollment: 74

Sponsor: Bezmialem Vakif University

Summary

In this prospective controlled study, 74 adults undergoing elective bilateral tonsillectomy for recurrent tonsillitis were consecutively enrolled and sequentially assigned in a 1:1 ratio to receive either local submucosal dexamethasone (8 mg, 1 mL; n = 37) or an equal volume of normal saline (n = 37). The primary outcome was the change in postoperative uvula edema score between postoperative days 1 and 3. Secondary outcomes included postoperative uvula edema grades, pain, dysphagia, speech difficulty, and breathing discomfort assessed on postoperative days 1, 3, and 5.

Eligibility Criteria

Inclusion Criteria: Adults aged 18-44 years Scheduled for elective bilateral tonsillectomy Indication for surgery: recurrent tonsillitis Exclusion Criteria: Age \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT03079453). StuddyBuddy aggregates publicly available trial information.